Replies to post #24076 on Marker Therapeutics Inc (MRKR)

[Phantom Lord]

You are 100% correct. I just regurgitated the info given without digging too far into all of it. Shame on me. I just sent a follow up to IR for clarification and will report back when I get a response.

[Phantom Lord]

A little confusion. IR thought I was requesting info on the TNBC data in general, not in regard to a specific trial. Their response to the specific trial, NCT02593227, is below:

If you take a look at our earnings call, (HERE) we had a couple of months ago, Dr. Kenney stated, "We are currently analyzing the data and anticipate reporting results in the third quarter this year. The interim analysis will focus on patient immune responses following vaccination with varying doses of TPIV200 for patients treated with or without preliminary type of hospital line."

So within the next couple of months we should get some data on this trial.

[tomjohnforch3]

So what exactly would this mean if they lied? Other than that, it could've just been gross incompetence, right?